Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population

AbstractIntroduction and aimIt is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2 diabetes risk. However, whether serum ALT levels could improve the discrimination of type 2 diabetes remains unclear...

Full description

Saved in:
Bibliographic Details
Published inAnnals of hepatology Vol. 18; no. 2; pp. 298 - 303
Main Authors Li, Yaru, Wang, Jing, Han, Xu, Hu, Hua, Wang, Fei, Yu, Caizheng, Yuan, Jing, Yao, Ping, Li, Xiulou, Yang, Kun, Miao, Xiaoping, Wei, Sheng, Wang, Youjie, Chen, Weihong, Liang, Yuan, Zhang, Xiaomin, Guo, Huan, Yang, Handong, Wu, Tangchun, He, Meian
Format Journal Article
LanguageEnglish
Published Mexico Elsevier 01.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract AbstractIntroduction and aimIt is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2 diabetes risk. However, whether serum ALT levels could improve the discrimination of type 2 diabetes remains unclear. MethodsThe data was derived from the Dongfeng-Tongji cohort study, which was established in 2008 and followed until October 2013. A total of 17,173 participants free of type 2 diabetes at baseline were included and 1159 participants developed diabetes after 4.51 (0.61) years of follow-up. Cox proportional hazard regression model was used to calculate the hazard ratios (HRs) for the association between ALT and AST levels with incident diabetes risk. Receiver-operating characteristic (ROC) curves analysis was used to evaluate the predictive accuracy of models incorporating traditional risk factors with and without ALT. ResultsCompared with the lowest quartile of ALT and AST levels, the highest quartile had a significantly higher risk of developing type 2 diabetes (HR: 2.17 [95% CI: 1.78–2.65] and 1.29 [1.08–1.54], respectively) after adjustment for potential confounders. The addition of ALT levels into the traditional risk factors did not improve the predictive ability of type 2 diabetes, with AUC increase from 0.772 to 0.774; P= 0.86. ConclusionsAlthough elevated ALT or AST levels increased incident type 2diabetes risk, addition of ALT levels into the prediction model did not improve the discrimination of type 2 diabetes.
AbstractList Introduction and aim: It is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2 diabetes risk. However, whether serum ALT levels could improve the discrimination of type 2 diabetes remains unclear. Methods: The data was derived from the Dongfeng-Tongji cohort study, which was established in 2008 and followed until October 2013. A total of 17,173 participants free of type 2 diabetes at baseline were included and 1159 participants developed diabetes after 4.51 (0.61) years of follow-up. Cox proportional hazard regression model was used to calculate the hazard ratios (HRs) for the association between ALT and AST levels with incident diabetes risk. Receiver-operating characteristic (ROC) curves analysis was used to evaluate the predictive accuracy of models incorporating traditional risk factors with and without ALT. Results: Compared with the lowest quartile of ALT and AST levels, the highest quartile had a significantly higher risk of developing type 2 diabetes (HR: 2.17 [95% CI: 1.78–2.65] and 1.29 [1.08–1.54], respectively) after adjustment for potential confounders. The addition of ALT levels into the traditional risk factors did not improve the predictive ability of type 2 diabetes, with AUC increase from 0.772 to 0.774; P = 0.86. Conclusions: Although elevated ALT or AST levels increased incident type 2diabetes risk, addition of ALT levels into the prediction model did not improve the discrimination of type 2 diabetes.
INTRODUCTION AND AIMIt is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2 diabetes risk. However, whether serum ALT levels could improve the discrimination of type 2 diabetes remains unclear. METHODSThe data was derived from the Dongfeng-Tongji cohort study, which was established in 2008 and followed until October 2013. A total of 17,173 participants free of type 2 diabetes at baseline were included and 1159 participants developed diabetes after 4.51 (0.61) years of follow-up. Cox proportional hazard regression model was used to calculate the hazard ratios (HRs) for the association between ALT and AST levels with incident diabetes risk. Receiver-operating characteristic (ROC) curves analysis was used to evaluate the predictive accuracy of models incorporating traditional risk factors with and without ALT. RESULTSCompared with the lowest quartile of ALT and AST levels, the highest quartile had a significantly higher risk of developing type 2 diabetes (HR: 2.17 [95% CI: 1.78-2.65] and 1.29 [1.08-1.54], respectively) after adjustment for potential confounders. The addition of ALT levels into the traditional risk factors did not improve the predictive ability of type 2 diabetes, with AUC increase from 0.772 to 0.774; P=0.86. CONCLUSIONSAlthough elevated ALT or AST levels increased incident type 2diabetes risk, addition of ALT levels into the prediction model did not improve the discrimination of type 2 diabetes.
It is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2 diabetes risk. However, whether serum ALT levels could improve the discrimination of type 2 diabetes remains unclear. The data was derived from the Dongfeng-Tongji cohort study, which was established in 2008 and followed until October 2013. A total of 17,173 participants free of type 2 diabetes at baseline were included and 1159 participants developed diabetes after 4.51 (0.61) years of follow-up. Cox proportional hazard regression model was used to calculate the hazard ratios (HRs) for the association between ALT and AST levels with incident diabetes risk. Receiver-operating characteristic (ROC) curves analysis was used to evaluate the predictive accuracy of models incorporating traditional risk factors with and without ALT. Compared with the lowest quartile of ALT and AST levels, the highest quartile had a significantly higher risk of developing type 2 diabetes (HR: 2.17 [95% CI: 1.78-2.65] and 1.29 [1.08-1.54], respectively) after adjustment for potential confounders. The addition of ALT levels into the traditional risk factors did not improve the predictive ability of type 2 diabetes, with AUC increase from 0.772 to 0.774; P=0.86. Although elevated ALT or AST levels increased incident type 2diabetes risk, addition of ALT levels into the prediction model did not improve the discrimination of type 2 diabetes.
AbstractIntroduction and aimIt is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2 diabetes risk. However, whether serum ALT levels could improve the discrimination of type 2 diabetes remains unclear. MethodsThe data was derived from the Dongfeng-Tongji cohort study, which was established in 2008 and followed until October 2013. A total of 17,173 participants free of type 2 diabetes at baseline were included and 1159 participants developed diabetes after 4.51 (0.61) years of follow-up. Cox proportional hazard regression model was used to calculate the hazard ratios (HRs) for the association between ALT and AST levels with incident diabetes risk. Receiver-operating characteristic (ROC) curves analysis was used to evaluate the predictive accuracy of models incorporating traditional risk factors with and without ALT. ResultsCompared with the lowest quartile of ALT and AST levels, the highest quartile had a significantly higher risk of developing type 2 diabetes (HR: 2.17 [95% CI: 1.78–2.65] and 1.29 [1.08–1.54], respectively) after adjustment for potential confounders. The addition of ALT levels into the traditional risk factors did not improve the predictive ability of type 2 diabetes, with AUC increase from 0.772 to 0.774; P= 0.86. ConclusionsAlthough elevated ALT or AST levels increased incident type 2diabetes risk, addition of ALT levels into the prediction model did not improve the discrimination of type 2 diabetes.
Author Yu, Caizheng
Liang, Yuan
He, Meian
Yao, Ping
Yang, Kun
Miao, Xiaoping
Zhang, Xiaomin
Wang, Jing
Chen, Weihong
Han, Xu
Hu, Hua
Wang, Fei
Li, Yaru
Wang, Youjie
Wu, Tangchun
Wei, Sheng
Yuan, Jing
Li, Xiulou
Guo, Huan
Yang, Handong
Author_xml – sequence: 1
  fullname: Li, Yaru
– sequence: 2
  fullname: Wang, Jing
– sequence: 3
  fullname: Han, Xu
– sequence: 4
  fullname: Hu, Hua
– sequence: 5
  fullname: Wang, Fei
– sequence: 6
  fullname: Yu, Caizheng
– sequence: 7
  fullname: Yuan, Jing
– sequence: 8
  fullname: Yao, Ping
– sequence: 9
  fullname: Li, Xiulou
– sequence: 10
  fullname: Yang, Kun
– sequence: 11
  fullname: Miao, Xiaoping
– sequence: 12
  fullname: Wei, Sheng
– sequence: 13
  fullname: Wang, Youjie
– sequence: 14
  fullname: Chen, Weihong
– sequence: 15
  fullname: Liang, Yuan
– sequence: 16
  fullname: Zhang, Xiaomin
– sequence: 17
  fullname: Guo, Huan
– sequence: 18
  fullname: Yang, Handong
– sequence: 19
  fullname: Wu, Tangchun
– sequence: 20
  fullname: He, Meian
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31040092$$D View this record in MEDLINE/PubMed
BookMark eNo9kUtr3TAQRr1IaR7tLygULbuxo4ctXW8K5dJHIJBF2rUYWeMbObLkSHbg_vvYuWlWA8P3nYE5l8VZiAGL4gujFaNMXg8VxAecKk6ZqiivKGVnxQWTsim53LHz4jLngdJaNIx_LM4FozWlLb8onu4xLSMBD8EFJHOCkGF0ATISj8_oM5kSWtfNZD5OSDixDgzOmEly-ZHAGMOBABmdtR5LOKAlECxBbzH5I9k_rNiVNcVp8TC7GD4VH3rwGT-_zavi36-ff_d_ytu73zf7H7dlVys2lxaY4NYoTmvZyxp53dqmVgjcdMKyHvmuUQwlq420oFppubHS1B0XnGIjxFVxc-LaCIOekhshHXUEp18XMR00pNl1HrXqWmV6qVjfqloZ00pEZnvFm51BAxvr24k1pfi0YJ716HKHfv0axiVrztlOUC5Eu0bFKdqlmHPC_v00o3pzpQf96kpvrjTlenW1tr6-HVjMiPa981_UGvh-CqxG8Nlh0p13wXXgH_GIeYhLCus3NdN5Jer7Tf1mnrWCUto04gVhcKrJ
CitedBy_id crossref_primary_10_1007_s13410_024_01334_4
crossref_primary_10_1097_MD_0000000000018963
crossref_primary_10_1111_liv_15133
crossref_primary_10_1136_bmjopen_2023_074007
crossref_primary_10_1038_s41598_021_82981_z
crossref_primary_10_1016_j_diabres_2022_109968
crossref_primary_10_2478_enr_2023_0024
crossref_primary_10_1038_s41598_024_60092_9
crossref_primary_10_3390_life13091881
crossref_primary_10_1155_2022_5648896
crossref_primary_10_3389_fendo_2023_1266692
crossref_primary_10_3390_ijms24087499
Cites_doi 10.2337/dc11-0919
10.2337/dc08-1870
10.1002/hep.24769
10.1093/ije/dys053
10.1007/s00125-005-0097-z
10.1001/archinte.167.10.1068
10.2337/diabetes.53.10.2623
10.1007/s00125-008-1232-4
10.2337/diacare.26.3.725
10.2337/dc06-2089
10.1309/AJCPO47VAWYRIDHG
10.1186/1758-5996-6-14
10.7326/0003-4819-136-8-200204160-00006
10.1093/aje/kws469
10.1136/jech-2015-205518
10.2337/diabetes.51.6.1889
10.1016/j.metabol.2007.10.015
10.2337/dc13-0593
10.1016/S1262-3636(07)70229-X
10.2337/dc11-1853
10.2337/dc07-2184
10.1001/jama.2013.168118
10.1038/oby.2007.527
10.2337/diacare.27.3.727
10.1053/j.gastro.2008.09.018
ContentType Journal Article
Copyright Fundación Clínica Médica Sur, A.C.
Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.
Copyright_xml – notice: Fundación Clínica Médica Sur, A.C.
– notice: Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOA
DOI 10.1016/j.aohep.2017.02.001
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 303
ExternalDocumentID oai_doaj_org_article_7c97bf671f9747bb96ee1df7258beba3
10_1016_j_aohep_2017_02_001
31040092
1_s2_0_S1665268119300055
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
.1-
.FO
0R~
0SF
1P~
23M
2WC
53G
5GY
77H
AAEDW
AAKDD
AALRI
AAXUO
ABXHO
ADBBV
ADVLN
AENEX
AEVXI
AEXQZ
AFCTW
AFJKZ
AFRHN
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APOWU
BAWUL
DIK
EBD
EBS
EMOBN
F5P
FDB
GROUPED_DOAJ
GX1
M41
NCXOZ
OC.
OK1
ON0
P2P
ROL
RSH
SV3
TR2
Z5R
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c471t-da132db72046f64e249d547ea2bc3d1fe28571e614b6da796d2bd6b4c2320e533
IEDL.DBID DOA
ISSN 1665-2681
IngestDate Fri Oct 04 13:13:04 EDT 2024
Fri Aug 16 22:31:12 EDT 2024
Thu Sep 26 18:04:24 EDT 2024
Sat Sep 28 08:30:49 EDT 2024
Tue Oct 15 22:56:18 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Type 2 diabetes
Alanine aminotransferase
Prediction model
Language English
License Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c471t-da132db72046f64e249d547ea2bc3d1fe28571e614b6da796d2bd6b4c2320e533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/7c97bf671f9747bb96ee1df7258beba3
PMID 31040092
PQID 2218302339
PQPubID 23479
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_7c97bf671f9747bb96ee1df7258beba3
proquest_miscellaneous_2218302339
crossref_primary_10_1016_j_aohep_2017_02_001
pubmed_primary_31040092
elsevier_clinicalkeyesjournals_1_s2_0_S1665268119300055
PublicationCentury 2000
PublicationDate 2019-03-01
PublicationDateYYYYMMDD 2019-03-01
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Mexico
PublicationPlace_xml – name: Mexico
PublicationTitle Annals of hepatology
PublicationTitleAlternate Ann Hepatol
PublicationYear 2019
Publisher Elsevier
Publisher_xml – name: Elsevier
References Zhou (10.1016/j.aohep.2017.02.001_bib0190) 2013; 36
Glumer (10.1016/j.aohep.2017.02.001_bib0180) 2004; 27
Chien (10.1016/j.aohep.2017.02.001_bib0185) 2009; 52
Wilson (10.1016/j.aohep.2017.02.001_bib0290) 2007; 167
Xu (10.1016/j.aohep.2017.02.001_bib0280) 2015; 144
Kunutsor (10.1016/j.aohep.2017.02.001_bib0205) 2013; 178
Monami (10.1016/j.aohep.2017.02.001_bib0275) 2008; 57
Stern (10.1016/j.aohep.2017.02.001_bib0285) 2002; 136
Fraser (10.1016/j.aohep.2017.02.001_bib0250) 2009; 32
Mohan (10.1016/j.aohep.2017.02.001_bib0170) 2005; 53
Schulze (10.1016/j.aohep.2017.02.001_bib0175) 2007; 30
Ahn (10.1016/j.aohep.2017.02.001_bib0200) 2014; 6
Xu (10.1016/j.aohep.2017.02.001_bib0150) 2013; 310
Pearson (10.1016/j.aohep.2017.02.001_bib0160) 2003; 9
Sato (10.1016/j.aohep.2017.02.001_bib0245) 2008; 31
Lindstrom (10.1016/j.aohep.2017.02.001_bib0165) 2003; 26
Nguyen (10.1016/j.aohep.2017.02.001_bib0195) 2011; 34
Andre (10.1016/j.aohep.2017.02.001_bib0210) 2005; 31
Venkatesan (10.1016/j.aohep.2017.02.001_bib0265) 2012; 55
Reynolds (10.1016/j.aohep.2017.02.001_bib0225) 2007; 15
Wang (10.1016/j.aohep.2017.02.001_bib0220) 2013; 42
Xu (10.1016/j.aohep.2017.02.001_bib0215) 2015; 69
Zhou (10.1016/j.aohep.2017.02.001_bib0230) 2002; 15
Sung (10.1016/j.aohep.2017.02.001_bib0260) 2012; 35
Goessling (10.1016/j.aohep.2017.02.001_bib0240) 2008; 135
Ramachandran (10.1016/j.aohep.2017.02.001_bib0155) 2006; 49
(10.1016/j.aohep.2017.02.001_bib0235) 2012; 35
Vozarova (10.1016/j.aohep.2017.02.001_bib0255) 2002; 51
Hanley (10.1016/j.aohep.2017.02.001_bib0270) 2004; 53
References_xml – volume: 34
  start-page: 2603
  year: 2011
  ident: 10.1016/j.aohep.2017.02.001_bib0195
  article-title: Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study
  publication-title: Diabetes Care
  doi: 10.2337/dc11-0919
  contributor:
    fullname: Nguyen
– volume: 32
  start-page: 741
  year: 2009
  ident: 10.1016/j.aohep.2017.02.001_bib0250
  article-title: Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1870
  contributor:
    fullname: Fraser
– volume: 55
  start-page: 968
  year: 2012
  ident: 10.1016/j.aohep.2017.02.001_bib0265
  article-title: Potential mechanisms underlying the associations between liver enzymes and risk for type 2 diabetes
  publication-title: Hepatology
  doi: 10.1002/hep.24769
  contributor:
    fullname: Venkatesan
– volume: 42
  start-page: 731
  year: 2013
  ident: 10.1016/j.aohep.2017.02.001_bib0220
  article-title: Cohort Profile: the Dongfeng-Tongji cohort study of retired workers
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dys053
  contributor:
    fullname: Wang
– volume: 49
  start-page: 289
  year: 2006
  ident: 10.1016/j.aohep.2017.02.001_bib0155
  article-title: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)
  publication-title: Diabetologia
  doi: 10.1007/s00125-005-0097-z
  contributor:
    fullname: Ramachandran
– volume: 15
  start-page: 83
  year: 2002
  ident: 10.1016/j.aohep.2017.02.001_bib0230
  article-title: Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults – study on optimal cut-off points of body mass index and waist circumference in Chinese adults
  publication-title: Biomed Environ Sci
  contributor:
    fullname: Zhou
– volume: 167
  start-page: 1068
  year: 2007
  ident: 10.1016/j.aohep.2017.02.001_bib0290
  article-title: Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.167.10.1068
  contributor:
    fullname: Wilson
– volume: 53
  start-page: 2623
  year: 2004
  ident: 10.1016/j.aohep.2017.02.001_bib0270
  article-title: Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study
  publication-title: Diabetes
  doi: 10.2337/diabetes.53.10.2623
  contributor:
    fullname: Hanley
– volume: 52
  start-page: 443
  year: 2009
  ident: 10.1016/j.aohep.2017.02.001_bib0185
  article-title: A prediction model for type 2 diabetes risk among Chinese people
  publication-title: Diabetologia
  doi: 10.1007/s00125-008-1232-4
  contributor:
    fullname: Chien
– volume: 9
  start-page: 57
  year: 2003
  ident: 10.1016/j.aohep.2017.02.001_bib0160
  article-title: Identifying individuals at risk for the development of type 2 diabetes mellitus
  publication-title: Am J Manag Care
  contributor:
    fullname: Pearson
– volume: 26
  start-page: 725
  year: 2003
  ident: 10.1016/j.aohep.2017.02.001_bib0165
  article-title: The diabetes risk score: a practical tool to predict type 2 diabetes risk
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.3.725
  contributor:
    fullname: Lindstrom
– volume: 30
  start-page: 510
  year: 2007
  ident: 10.1016/j.aohep.2017.02.001_bib0175
  article-title: An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc06-2089
  contributor:
    fullname: Schulze
– volume: 144
  start-page: 423
  year: 2015
  ident: 10.1016/j.aohep.2017.02.001_bib0280
  article-title: Limiting the testing of AST: a diagnostically nonspecific enzyme
  publication-title: Am J Clin Pathol
  doi: 10.1309/AJCPO47VAWYRIDHG
  contributor:
    fullname: Xu
– volume: 6
  start-page: 14
  year: 2014
  ident: 10.1016/j.aohep.2017.02.001_bib0200
  article-title: The association between liver enzymes and risk of type 2 diabetes: the Namwon study
  publication-title: Diabetol Metab Syndr
  doi: 10.1186/1758-5996-6-14
  contributor:
    fullname: Ahn
– volume: 136
  start-page: 575
  year: 2002
  ident: 10.1016/j.aohep.2017.02.001_bib0285
  article-title: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-136-8-200204160-00006
  contributor:
    fullname: Stern
– volume: 178
  start-page: 159
  year: 2013
  ident: 10.1016/j.aohep.2017.02.001_bib0205
  article-title: Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kws469
  contributor:
    fullname: Kunutsor
– volume: 69
  start-page: 1040
  year: 2015
  ident: 10.1016/j.aohep.2017.02.001_bib0215
  article-title: Liver enzymes and incident diabetes in China: a prospective analysis of 10764 participants in the Guangzhou Biobank Cohort Study
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech-2015-205518
  contributor:
    fullname: Xu
– volume: 51
  start-page: 1889
  year: 2002
  ident: 10.1016/j.aohep.2017.02.001_bib0255
  article-title: High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.6.1889
  contributor:
    fullname: Vozarova
– volume: 57
  start-page: 387
  year: 2008
  ident: 10.1016/j.aohep.2017.02.001_bib0275
  article-title: Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2007.10.015
  contributor:
    fullname: Monami
– volume: 53
  start-page: 759
  year: 2005
  ident: 10.1016/j.aohep.2017.02.001_bib0170
  article-title: A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects
  publication-title: J Assoc Physicians India
  contributor:
    fullname: Mohan
– volume: 36
  start-page: 3944
  year: 2013
  ident: 10.1016/j.aohep.2017.02.001_bib0190
  article-title: Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey
  publication-title: Diabetes Care
  doi: 10.2337/dc13-0593
  contributor:
    fullname: Zhou
– volume: 31
  start-page: 542
  year: 2005
  ident: 10.1016/j.aohep.2017.02.001_bib0210
  article-title: Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study
  publication-title: Diabetes Metab
  doi: 10.1016/S1262-3636(07)70229-X
  contributor:
    fullname: Andre
– volume: 35
  start-page: 717
  year: 2012
  ident: 10.1016/j.aohep.2017.02.001_bib0260
  article-title: Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc11-1853
  contributor:
    fullname: Sung
– volume: 35
  start-page: S11
  issue: Suppl. 1
  year: 2012
  ident: 10.1016/j.aohep.2017.02.001_bib0235
  article-title: Standards of medical care in diabetes – 2012
  publication-title: Diabetes Care
– volume: 31
  start-page: 1230
  year: 2008
  ident: 10.1016/j.aohep.2017.02.001_bib0245
  article-title: Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study
  publication-title: Diabetes Care
  doi: 10.2337/dc07-2184
  contributor:
    fullname: Sato
– volume: 310
  start-page: 948
  year: 2013
  ident: 10.1016/j.aohep.2017.02.001_bib0150
  article-title: Prevalence and control of diabetes in Chinese adults
  publication-title: JAMA
  doi: 10.1001/jama.2013.168118
  contributor:
    fullname: Xu
– volume: 15
  start-page: 10
  year: 2007
  ident: 10.1016/j.aohep.2017.02.001_bib0225
  article-title: Prevalence and risk factors of overweight and obesity in China
  publication-title: Obesity
  doi: 10.1038/oby.2007.527
  contributor:
    fullname: Reynolds
– volume: 27
  start-page: 727
  year: 2004
  ident: 10.1016/j.aohep.2017.02.001_bib0180
  article-title: A Danish diabetes risk score for targeted screening: the Inter99 study
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.3.727
  contributor:
    fullname: Glumer
– volume: 135
  year: 2008
  ident: 10.1016/j.aohep.2017.02.001_bib0240
  article-title: Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.09.018
  contributor:
    fullname: Goessling
SSID ssj0043512
Score 2.3115664
Snippet AbstractIntroduction and aimIt is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with...
It is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2...
INTRODUCTION AND AIMIt is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased...
Introduction and aim: It is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with...
SourceID doaj
proquest
crossref
pubmed
elsevier
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 298
SubjectTerms Age Factors
Aged
Alanine aminotransferase
Alanine Transaminase - blood
Biomarkers - blood
China - epidemiology
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - epidemiology
Female
Gastroenterology and Hepatology
Humans
Incidence
Male
Middle Aged
Prediction model
Prognosis
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Type 2 diabetes
Up-Regulation
Title Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1665268119300055
https://www.ncbi.nlm.nih.gov/pubmed/31040092
https://search.proquest.com/docview/2218302339
https://doaj.org/article/7c97bf671f9747bb96ee1df7258beba3
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07b9swECYKD0GXIq82SpqABTJWqCnzYY1tESMI4C6tgWwEKZ4QBLbsRPKQf587UjKaIciSUYIexN2R_I78-B1jl7WaYqdRMjeAuar0Y5VjZqvzSpY1CeAJGeg08vyPvl7Im1t1-1-pL-KEJXngZLgfpiqNr7URNSFf70sNIEJtCjX14F3S-RRqSKbSGIwYIO1z6sjhmopBbygyu9z6DkiqUpgk1ylezElRuv_F1PQa9IxT0GyffeqxI_-Z2nzAPkBzyPbm_e74EXvAjr9dcSIr4jXvYilworq0wJdEDmr55pGe7jitvPKCDyuvnBjmPBYe4o6v4qJFjiNN4K4JHKiS9_KJU61twG9tdkW_jtlidvXv93Xel1RA4xvR5cFh9hk8VabRtZaAyVdQ0oArfDUJooZiqowAnLO9Ds6UOhQ-aC8rBF5jQGj4mY2adQMnjDuHYA_dUaqqxqxHe-0cVLTLV07w7UnGvg9GtZuknGEHStm9jT6w5AM7LohYl7FfZPjdoyR7HW9gMNg-GOxbwZAxM7jNDidLcSyEtu-YrRW2xd_ZvxQZFBiIXwm2qox9G7xssYPRrolrYL1tbUEgEpHNpMzYl-T-XSMRG0tSrTp9j8afsY9ojzIR3L6yUfe4hXNEPJ2_iMH9DMj7_Mg
link.rule.ids 315,786,790,870,2115,27955,27956
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+alanine+transaminase+levels+predict+type+2+diabetes+risk+among+a+middle-aged+and+elderly+Chinese+population&rft.jtitle=Annals+of+hepatology&rft.au=Li%2C+Yaru&rft.au=Wang%2C+Jing&rft.au=Han%2C+Xu&rft.au=Hu%2C+Hua&rft.date=2019-03-01&rft.issn=1665-2681&rft.volume=18&rft.issue=2&rft.spage=298&rft_id=info:doi/10.1016%2Fj.aohep.2017.02.001&rft_id=info%3Apmid%2F31040092&rft.externalDocID=31040092
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F16652681%2FS1665268119X00022%2Fcov150h.gif